Loading...

Home
ETF
LIXT

LIXT

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

LIXT News

LIXTE Biotechnology Partners with IBN to Enhance Cancer Treatment Awareness

Jan 13 2026Globenewswire

Lixte Biotechnology Secures $4.3 Million Financing for Cancer Treatment Development

Dec 22 2025Globenewswire

Lixte Biotechnology Secures $4.3 Million in Registered Direct Offering

Dec 18 2025Newsfilter

LIXTE Acquires Liora Technologies to Advance Cancer Treatment Standards

Nov 25 2025Newsfilter

Biotech Stocks Surge After Hours: Insider Purchases, Trial Progress, and Strategic Partnerships Drive Growth

Sep 11 2025NASDAQ.COM

LIXTE Unveils LB-100 at Inaugural Global Conference on Oncogenic Signaling Activation for Cancer Treatment in 24/7 Market News

Aug 27 2025Yahoo Finance

Around-the-Clock Market Update: LIXTE Aims at Significant Unaddressed Oncology Markets

Aug 25 2025Newsfilter

24/7 Market Update: LIXTE Biotechnology Focus - Reevaluating the "Excessive Benefits" Approach for LB-100

Aug 19 2025Newsfilter

24/7 Market Update: LIXTE Biotechnology Focus - Reevaluating the "Excessive Benefits" Approach for LB-100

Aug 19 2025Yahoo Finance

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

Aug 15 2025Yahoo Finance

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025

Aug 14 2025Newsfilter

Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering

Jul 09 2025Globenewswire

Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket

Jul 07 2025Benzinga

Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates

Jul 03 2025Benzinga

Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market

Jul 02 2025Newsfilter

Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market

Jul 01 2025Newsfilter